Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 166   

Articles published

BMY 74.81 +0.15 (0.20%)
price chart
Bristol-Myers Squibb Co. Announces 30% Advance In Q2 Earnings
The company said revenue for the quarter rose 17.1% to $4.87 billion. This was up from $4.16 billion last year. Bristol-Myers Squibb Co. earnings at a glance: -Earnings (Q2): $1.16 Bln. vs. $0.89 Bln. last year. -Earnings Growth (Y-o-Y): 30.3% -EPS (Q2 ...
Capital Planning Advisors Lowers stake in Bristol-Myers Squibb Co (BMY)  Trade Calls
Bristol-Myers Squibb Co (NYSE:BMY) & Yandex NV (NASDAQ:YNDX) Stocks in ...  Money News (press release)
Earnings Reaction History: Bristol Myers Squibb Co, 30.0% Follow-Through ...
Bristol Myers Squibb Co ( BMY ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.
Analysts Advise About Bristol-Myers Squibb Co (NYSE:BMY)
Bristol-Myers Squibb Co (NYSE:BMY) stock is currently trading at about $75.06 and lots of rating firms seem to have a target price set on the stock.
Mizuho Securities Usa adds Bristol-Myers Squibb Co (BMY) to its portfolio  Trade Calls
Bollard Group buys $12915776 stake in Bristol-Myers Squibb Co (BMY)  Market Digest
Bristol-Myers Squibb Co (NYSE:BMY) Analyst Research Summary
Bristol-Myers Squibb Co (NYSE:BMY) stock is currently trading at about $75.50 and lots of rating firms seem to have a target price set on the stock.
Office Depot Inc (NASDAQ:ODP) & Bristol-Myers Squibb Co (NYSE:BMY) Trend ...  Money News (press release)
Strategic Advisors Lowers stake in Bristol-Myers Squibb Co (BMY)  Trade Calls
Comprehensive Report on: McEwen Mining Inc. (NYSE:MUX), Bristol-Myers Squibb ...
Last Trade: The Company closed its last session at $4.28 with the gain of 9.46%. The market capitalization of the company is $1.2 Billion, with the average Volume of 4.19 Million. The stock currently has its 52-Week High range of $4.92 and 52-week low ...
Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals
NEW YORK & STOCKHOLM--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Cormorant Pharmaceuticals announced today that Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormorant, a private, Stockholm, ...
Bristol-Myers buys Swedish company with immunotherapy treatment  MarketWatch
Bristol-Myers Squibb Buys Privately Held Cormorant Pharmaceuticals  Benzinga
Where Bristol-Myers Squibb Co (NYSE:BMY) Is Betting $520 Million
Bristol-Myers Squibb Co (NYSE:BMY) has agreed to acquire privately-held Cormorant Pharmaceuticals. Boards on both sides and shareholders on the side of Cormorant have approved the buyout.
Newman Dignan Sheerar Lowers stake in Bristol-Myers Squibb Co (BMY)  Trade Calls
BRIEF-Bristol-Myers squibb reports Q2 non-gaap EPS $0.69
July 28 Bristol-Myers Squibb Co : * Myers Squibb reports second quarter financial results. * Qtrly Opdivo worldwide revenues $840 million versus $122 million last year.
Friday Session Wrap for Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) closed at $74.81 after seeing 4861057 shares trade hands during the most recent session.
Alnylam Pharmaceuticals, (NASDAQ:ALNY) & Bristol-Myers Squibb Co (NYSE:BMY ...
On Monday, Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) gained 1.08% to $66.20. The share price is trading in a range of $60.47 - $66.47.